Evonik Health Care is the innovation hub for leading life science companies
KEY SERVICES
Reset all filters
01 1Evonik
Reset all filters
01 1GLYCINE
Reset all filters
01 1Germany
Reset all filters
01 1Active
Reset all filters
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2017-03-31
Pay. Date : 2016-12-27
DMF Number : 30393
Submission : 2016-03-02
Status : Active
Type : II
20
Evonik Rexim (nanning) Pharmaceutical Co Ltd, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Evonik Health Care is the innovation hub for leading life science companies
One of their notable products is GLYCINE, with a corresponding US DMF Number 30393.
Remarkably, this DMF maintains an Active status since its submission on March 02, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 31, 2017, and payment made on December 27, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II